Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic

[1] Cifkova R(2008)Blood pressure around the menopause: a population study J Hypertens 26 1976-1982

[2] Pitha J(2010)Hypertension alone or related to the metabolic syndrome in postmenopausal women Expert Rev Cardiovasc Ther 8 1541-1548

[3] Lejskova M(1998)Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet 351 1755-1762

[4] Lanska V(1991)Thiaside diuretics and the risk of hip fracture. Results from the Framingham study JAMA 265 370-373

[5] Zecova S(1998)Baumer AT, Grohe´ C, Kahlert S, Strehlow K, Rosenkranz. Estrogen modulates AT1 receptor gene expression in vitro and in vivo Circulation 97 2197-2201

[6] Nuzzo A(2000)Endothelin-1 induces NAD(P)H oxidase in human endothelial cells Biochem Biophys Res Commun 269 713-717

[7] Rossi R(2002)Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol Lancet 359 995-1003

[8] Modena MG(2013)Global consensus statement on Menopausal hormone therapy Climacteric 16 203-204

[9] Hansson L(2002)Hypertension after menopause Curr Hypertens Rep 4 464-470

[10] Zanchetti A(2012)Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging J Clin Endocrinol Metab. 97 1159-1168

[1] Cifkova R(2008)Blood pressure around the menopause: a population study J Hypertens 26 1976-1982

[2] Pitha J(2010)Hypertension alone or related to the metabolic syndrome in postmenopausal women Expert Rev Cardiovasc Ther 8 1541-1548

[3] Lejskova M(1998)Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet 351 1755-1762

[4] Lanska V(1991)Thiaside diuretics and the risk of hip fracture. Results from the Framingham study JAMA 265 370-373

[5] Zecova S(1998)Baumer AT, Grohe´ C, Kahlert S, Strehlow K, Rosenkranz. Estrogen modulates AT1 receptor gene expression in vitro and in vivo Circulation 97 2197-2201

[6] Nuzzo A(2000)Endothelin-1 induces NAD(P)H oxidase in human endothelial cells Biochem Biophys Res Commun 269 713-717

[7] Rossi R(2002)Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol Lancet 359 995-1003

[8] Modena MG(2013)Global consensus statement on Menopausal hormone therapy Climacteric 16 203-204

[9] Hansson L(2002)Hypertension after menopause Curr Hypertens Rep 4 464-470

[10] Zanchetti A(2012)Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging J Clin Endocrinol Metab. 97 1159-1168